about
Signaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsOxidative stress: a new risk factor for thyroid cancerThe RET/PTC3 oncogene activates classical NF-κB by stabilizing NIKFlavonoids, Thyroid Iodide Uptake and Thyroid Cancer-A Review.The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progressionMicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer.Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by 131I.A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas.Immune response in thyroid cancer: widening the boundaries.Molecular pathogenesis and mechanisms of thyroid cancerNovel approaches in anaplastic thyroid cancer therapyClinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancerA functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases the risk of papillary thyroid carcinoma.BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cellsMicroRNA-145 inhibits human papillary cancer TPC1 cell proliferation by targeting DUSP6Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancerNF-κB Mediates the Expression of TBX15 in Cancer Cells.RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells.NF-κB Essential Modulator (NEMO) Is Critical for Thyroid Function.Recent insights into the cell biology of thyroid angiofollicular units.The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma.microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.Thyroid: Medullary Carcinoma.MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF.MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.MicroRNAs in the thyroid.3-Hydroxy-4,7-megastigmadien-9-one, isolated from Ulva pertusa, attenuates TLR9-mediated inflammatory response by down-regulating mitogen-activated protein kinase and NF-κB pathways.Detection and a possible link between parvovirus B19 and thyroid cancer.Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer.In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.Effects of nuclear factor‑κB on the uptake of 131iodine and apoptosis of thyroid carcinoma cells.Preventive Potential of Resveratrol in Carcinogen-Induced Rat Thyroid Tumorigenesis.IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS.Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.Monoolein, isolated from , inhibits lipopolysaccharide-induced inflammatory response by attenuating mitogen-activated protein kinase and NF-κB pathwaysThe Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
P2860
Q26764899-FC36DC83-4F17-43A9-A259-258A906606B8Q28388902-4AFDF1C8-3D95-487E-A991-FFD706F96C76Q28511823-4E922853-3607-4B68-B79D-FC83BA92B8A6Q33838859-B6F67FC9-38D0-44D5-986F-3CA07661DD3FQ33978070-E864E76B-BDC6-48CE-83AA-D8000F7C7D1FQ34147480-77A310A0-47F8-4A2C-8514-039E06245AC0Q34174513-CD0A0257-FE38-43DA-A45F-555EE0223496Q34206340-09C9CFC2-D167-4A5E-A965-89AFFB20E19AQ34277465-1F1A947B-2A88-4FBD-B4C3-558E0A9D3B97Q34310495-82BE1F49-9A86-47B2-A73F-ABF0A4CFDA5FQ34329018-4F8BC21F-7FC7-4E33-9136-5B46388AB92CQ34458018-209F7582-5F61-4ED3-B524-E1F9AB769022Q34595104-F9AE3051-9D0A-480A-BC30-AF54C50E5FF5Q35181543-10500393-A580-4BC8-A2F8-B0E351F769D1Q35951005-0A4970BA-EF15-4C25-AA57-E0D7A1A45EC0Q35959029-862BF8AF-3C79-4E57-B904-0632163D4B0AQ36012586-1DE6ED75-459D-4FBC-A878-753E08236D1AQ36057640-D0B6B2AC-87E6-4B96-A8D8-943AD7ADFF4DQ36289839-75736FCA-82F4-4388-870A-FB44F4BEDD1AQ36674674-6A826070-5B0D-411F-9B3A-B2396C5BBFC4Q36724051-C5C955AA-87DC-4F9D-A280-D8270BF1CC53Q36738884-EAE7CF5F-F242-47C9-8AED-068119DD3470Q36878582-E8126FE7-B5CD-45E3-8568-286358116777Q37591712-7B42A1D8-53FC-407C-9B56-CA9F12B6CBC2Q37709381-10B28623-C94D-472F-AC0E-5BB77B55FF39Q38719449-AF23C161-350D-4F9C-84A2-98B7614D8262Q39030847-08394701-2592-4EE1-9118-2CB490F29C7EQ39114139-7927FB99-8D1E-4865-B9A6-BB328CB2993AQ40158562-590D43CD-92ED-4E21-B8CE-CE2F896EB373Q42376397-687954B1-EDBC-40C2-9989-ECA86105D263Q46054824-C8242B9F-5FD8-4971-A8C9-A80CB7CF9CC8Q49379264-3E88DFEA-F667-4D85-B8E3-80DB6F4D7A2EQ51745709-AD792BEF-5679-4F63-A83F-61AEDA0732DCQ53214604-FE3B2B03-5FDA-4753-9088-4353128BDBEEQ54258517-E3017801-4869-41E8-9208-CAA033229B2BQ54298509-C8E64293-2423-4A80-90E7-CEAD321B1CD1Q57212209-21892B69-EB52-437F-BA20-D061D0D00BCEQ58729438-03E1C372-7A2F-4E4F-BF08-38EE0CCED0E9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of NF-kappaB in thyroid cancer.
@en
Role of NF-kappaB in thyroid cancer.
@nl
type
label
Role of NF-kappaB in thyroid cancer.
@en
Role of NF-kappaB in thyroid cancer.
@nl
prefLabel
Role of NF-kappaB in thyroid cancer.
@en
Role of NF-kappaB in thyroid cancer.
@nl
P1476
Role of NF-kappaB in thyroid cancer
@en
P2093
Antonio Leonardi
Francesco Pacifico
P356
10.1016/J.MCE.2009.10.010
P577
2009-10-30T00:00:00Z